10,000-Person obesity study aims to unlock personalized treatment secrets
NCT ID NCT07666425
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This observational study will follow 10,000 adults with obesity or overweight to understand how the disease progresses and what factors predict treatment success. Researchers will analyze medical records from 2000 onward, looking at heart and metabolic complications over 5 to 10 years. The goal is to identify patient subgroups and build models that help tailor future therapies.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- What this could lead to
- If successful, this study could help doctors better predict which obesity treatments work best for different patient groups, leading to more personalized care.
- What could go wrong
- This is an observational study, not a treatment trial. It collects existing data and does not test any new drug or intervention, so it cannot directly improve health outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESE ADULTS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
IRCCS Azienda Ospedaliero - Universitaria di Bologna
RECRUITINGBologna, Bologna, 40138, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can patients power their own obesity research?
- Can antioxidant pills boost skin and blood carotenoids to improve cardiometabolic health?
- Can a tailored lifestyle plan outsmart Obesity-Related health risks?
- Shake off the weight? vibration therapy put to the test against obesity
- Could a daily probiotic help you feel fuller and eat less?
- Heart safety check for new Weight-Loss drug candidate